查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1455303

2024 年藥品供應鏈管理全球市場報告

Pharmaceutical Supply Chain Management Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年藥品供應鏈管理市場規模將大幅成長。預計到 2028 年將以 8.7% 的複合年成長率 (CAGR) 成長至 36.3 億美元。預測期內藥品供應鏈管理的預期成長可歸因於多種因素。這些措施包括增加精準醫療的採用、注重供應鏈內的彈性規劃、加強資料安全措施、與電子商務平台整合、引入即時監控和視覺化解決方案以及強調循環經濟等。業界的舉措。預測期內預計的主要趨勢包括數位轉型工作、持續的技術進步、整個供應鏈的協作和可見性的增強、對環境永續性的高度關注，以及整合分析和人工智慧以及引入區塊鏈技術以提高透明度等。和安全。

藥品需求的增加預計將推動藥品供應鏈管理市場的成長。藥品，包括為預防、治療和管理各種疾病而開發、製造和分銷的藥品，依賴有效的藥品供應鏈管理來實現高效的生產、分銷和監控。這確保了及時獲得基本醫療保健產品。例如，根據歐洲製藥工業協會聯合會2023年6月的資料，歐洲藥品產量將從2021年的3,473.1億美元（3,239.5億歐元）增加到2022年的3,642.6億美元（340億歐元）。成長4.88%。因此，醫藥產品需求的上升可望刺激醫藥供應鏈管理市場。

慢性病盛行率的增加預計將有助於藥品供應鏈管理市場的成長。慢性病的特徵是長期病情持續超過三個月，需要有效的藥品供應鏈管理，以確保一致、有效率地提供藥物和治療。這種方法可以幫助減少延誤、控制成本並確保及時獲得慢性病管理所需的藥物。美國國立衛生研究院 (NIH) 2023 年 1 月報告稱，研究表明，美國勞動年齡人群的慢性病發病率預計將大幅上升，50 歲以上的人至少與一名慢性病預計100人以上的人數將增加99.5 %。因此，慢性病盛行率的增加將成為藥品供應鏈管理市場的主要促進因素。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球藥品供應鏈管理市場的促進因素與阻礙因素
    • 市場驅動力
    • 市場限制
  • 2018-2023 年全球藥品供應鏈管理市場規模、表現與成長
  • 全球醫藥供應鏈管理市場規模及成長預測，2023-2028、2033

第6章市場區隔

  • 全球藥品供應鏈管理市場，按組成部分、績效和預測細分，2018-2023、2023-2028、2033
  • 解決方案
  • 服務
  • 全球藥品供應鏈管理市場，依部署模式、績效及預測細分，2018-2023、2023-2028、2033
  • 本地
  • 雲端基礎
  • 全球藥品供應鏈管理市場，依最終用途、績效及預測細分，2018-2023、2023-2028、2033
  • 保健品製造商
  • 醫療服務提供方
  • 代理銷售
  • 物流

第 7 章 區域與國家分析

  • 全球藥品供應鏈管理市場，按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球藥品供應鏈管理市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 醫藥供應鏈管理市場競爭格局
  • 醫藥供應鏈管理市場公司概況
    • McKesson Corporation
    • AmerisourceBergen Corporation
    • Cardinal Health Inc.
    • Oracle Corporation
    • SAP SE

第31章 其他重大及創新企業

  • DSV Panalpina
  • UPS Healthcare
  • Parexel International Corporation
  • Spectrum Health Medical Group
  • Vizient Inc
  • Catalent Inc.
  • Infor Inc.
  • Epicor Software Corporation
  • Alvogen Inc.
  • Vetter Pharma International GmbH
  • Almac Group
  • Manhattan Associates Inc.
  • Global Healthcare Exchange LLC
  • CryoPDP
  • Tecsys Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r16304

Pharmaceutical supply chain management involves the strategic planning, implementation, and control of the flow of pharmaceutical products and related information from manufacturers to end-users. The primary goal is to ensure the secure distribution of pharmaceuticals while maintaining product quality, safety, and compliance with regulatory requirements.

The main components of pharmaceutical supply chain management include solutions and services. Solutions encompass products, services, or strategic approaches designed to address specific challenges faced by pharmaceutical organizations. These solutions may involve a combination of resources, expertise, or technology. The deployment modes for these solutions can be either on-premise or cloud-based. Pharmaceutical supply chain management is utilized by various end-users, including healthcare manufacturers, healthcare providers, distributors, and logistics entities.

The pharmaceutical supply chain management market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical supply chain management market statistics, including the pharmaceutical supply chain management industry global market size, regional shares, competitors with pharmaceutical supply chain management market share, detailed pharmaceutical supply chain management market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical supply chain management industry. This pharmaceutical supply chain management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical supply chain management market size has grown strongly in recent years. It will grow from $2.36 billion in 2023 to $2.6 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth observed during the historical period in pharmaceutical supply chain management can be attributed to several factors. These include a heightened focus on regulatory compliance, the globalization of pharmaceutical operations, increased attention to risk management, a growing demand for personalized medicine, and a greater emphasis on sustainability practices within the supply chain. These factors collectively contributed to the evolution and advancement of pharmaceutical supply chain management during that period.

The pharmaceutical supply chain management market size is expected to see strong growth in the next few years. It will grow to $3.63 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The anticipated growth in the forecast period in pharmaceutical supply chain management can be attributed to various factors. These include the increasing adoption of precision medicine, a focus on resilience planning within the supply chain, enhanced measures for data security, integration with e-commerce platforms, the implementation of real-time monitoring and visibility solutions, and a growing emphasis on circular economy initiatives within the industry. Major trends expected in the forecast period encompass digital transformation initiatives, continuous technological advancements, increased collaboration and visibility across the supply chain, a strong focus on environmental sustainability, the integration of advanced analytics and artificial intelligence, and the adoption of blockchain technology to enhance transparency and security.

The increasing demand for pharmaceutical products is poised to drive the growth of the pharmaceutical supply chain management market. Pharmaceutical products, which encompass medications and drugs developed, manufactured, and distributed for the prevention, treatment, or management of various medical conditions, rely on effective pharmaceutical supply chain management for efficient production, distribution, and monitoring. This ensures timely access to essential healthcare products. For example, data from the European Federation of Pharmaceutical Industries and Associations in June 2023 indicates that the production value of pharmaceuticals in Europe rose from 347.31 billion USD (323,950 million euros) in 2021 to 364.26 billion USD (340,000 million euros) in 2022, representing a 4.88% increase. Hence, the growing demand for pharmaceutical products is expected to fuel the pharmaceutical supply chain management market.

The increasing prevalence of chronic diseases is anticipated to contribute to the growth of the pharmaceutical supply chain management market. Chronic diseases, characterized by long-lasting medical conditions persisting for three months or more, necessitate effective pharmaceutical supply chain management for a consistent and efficient flow of medications and treatments. This approach helps reduce delays, control costs, and ensure the timely availability of medications crucial for managing chronic conditions. As reported by the National Institutes of Health (NIH) in January 2023, research anticipates a substantial increase in the incidence of chronic illnesses within the U.S. working-age demographic, projecting a 99.5% surge in individuals aged 50 and above with at least one chronic disease between 2020 and 2035. Thus, the growing prevalence of chronic diseases is a key driver for the pharmaceutical supply chain management market.

Security issues within weak supply chain management are anticipated to impede the growth of the pharmaceutical supply chain management market. Weak supply chain management, particularly vulnerabilities such as data breaches, acts as a hindrance, limiting the market's expansion. Such security issues undermine data integrity and confidentiality, raise concerns about product safety and regulatory compliance, and have a negative impact on overall market growth. As reported in October 2022 by Check Point Software Technologies, a US-based software company, the third quarter of 2022 witnessed a significant global increase in cyberattacks, with the average weekly attacks per organization surpassing 1,130. The healthcare sector, including pharmaceuticals, was particularly targeted for ransomware, affecting one in 42 organizations, marking a 5% increase year-over-year. Consequently, security issues within weak supply chain management, notably data breaches, pose challenges to the pharmaceutical supply chain management market.

Key players in the pharmaceutical supply chain management market are actively developing innovative products such as multi-enterprise supply chain work management solutions to streamline processes and enhance collaboration across the pharmaceutical supply chain. Multi-enterprise supply chain work management solutions are specialized software or platforms designed to optimize various supply chain processes across multiple organizations within the pharmaceutical sector. For example, in April 2022, TraceLink Inc., a US-based company providing supply chain work management solutions, introduced the TraceLink supply chain work management solution-a multi-enterprise solution for the healthcare and life sciences industries. This solution aims to facilitate collaborative networks among companies and their trading partners, enhancing the performance of integrated supply planning and execution processes. It effectively manages supply chain issues and planning exceptions, such as material shortages, short shipments, and forecast changes. The solution offers actionable visibility and customizable business process templates for supply chain management, leading to improved fill rates, cost reduction, and enhanced supply plan performance.

In March 2022, Symplr Software LLC, a US-based company specializing in the development of governance, risk, and compliance management software for healthcare facilities, successfully acquired GreenLight Medical for an undisclosed amount. This strategic acquisition is intended to bolster Symplr's healthcare operations portfolio by integrating the specialized medical supply chain management software developed by GreenLight. By incorporating GreenLight's expertise and solutions, Symplr aims to offer its clients enhanced services in the supply chain management sector. This initiative seeks to address the challenges faced by healthcare organizations in supply procurement. GreenLight Medical, the acquired entity, is a US-based provider of healthcare supply chain management solutions.

Major companies operating in the pharmaceutical supply chain management market report are McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health Inc., Oracle Corporation, SAP SE, DSV Panalpina, UPS Healthcare, Parexel International Corporation, Spectrum Health Medical Group, Vizient Inc, Catalent Inc., Infor Inc., Epicor Software Corporation, Alvogen Inc., Vetter Pharma International GmbH , Almac Group, Manhattan Associates Inc., Global Healthcare Exchange LLC, CryoPDP, Tecsys Inc., Arvato Supply Chain Solutions, Terso Solution, Logitag Systems, Jump Technologies, Chain.io Inc.

Asia-Pacific was the largest region in the pharmaceutical supply chain management market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical supply chain management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical supply chain management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pharmaceutical supply chain management market includes revenues earned by entities by providing services such as logistics and distribution, cold chain management, inventory management, and quality control and assurance services that are used to optimize the pharmaceutical supply chain for the delivery of vital medications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The pharmaceutical supply chain management market consists of sales of cold chain equipment, warehouse automation systems, and automated guided vehicles. to provide pharmaceutical companies with opportunities to optimize the supply chain operations of pharmaceutical products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Supply Chain Management Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical supply chain management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical supply chain management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical supply chain management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Component: Solution; Service
  • 2) By Deployment Mode: On-Premise; Cloud Based
  • 3) By End-Use: Healthcare Manufacturers; Healthcare Providers; Distributors; Logistics
  • Companies Mentioned: McKesson Corporation; AmerisourceBergen Corporation; Cardinal Health Inc.; Oracle Corporation; SAP SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Supply Chain Management Market Characteristics

3. Pharmaceutical Supply Chain Management Market Trends And Strategies

4. Pharmaceutical Supply Chain Management Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pharmaceutical Supply Chain Management Market Size and Growth

  • 5.1. Global Pharmaceutical Supply Chain Management Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharmaceutical Supply Chain Management Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharmaceutical Supply Chain Management Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmaceutical Supply Chain Management Market Segmentation

  • 6.1. Global Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Solution
  • Service
  • 6.2. Global Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • On-Premise
  • Cloud Based
  • 6.3. Global Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Healthcare Manufacturers
  • Healthcare Providers
  • Distributors
  • Logistics

7. Pharmaceutical Supply Chain Management Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Supply Chain Management Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharmaceutical Supply Chain Management Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmaceutical Supply Chain Management Market

  • 8.1. Asia-Pacific Pharmaceutical Supply Chain Management Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmaceutical Supply Chain Management Market

  • 9.1. China Pharmaceutical Supply Chain Management Market Overview
  • 9.2. China Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmaceutical Supply Chain Management Market

  • 10.1. India Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmaceutical Supply Chain Management Market

  • 11.1. Japan Pharmaceutical Supply Chain Management Market Overview
  • 11.2. Japan Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmaceutical Supply Chain Management Market

  • 12.1. Australia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmaceutical Supply Chain Management Market

  • 13.1. Indonesia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmaceutical Supply Chain Management Market

  • 14.1. South Korea Pharmaceutical Supply Chain Management Market Overview
  • 14.2. South Korea Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmaceutical Supply Chain Management Market

  • 15.1. Western Europe Pharmaceutical Supply Chain Management Market Overview
  • 15.2. Western Europe Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmaceutical Supply Chain Management Market

  • 16.1. UK Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmaceutical Supply Chain Management Market

  • 17.1. Germany Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmaceutical Supply Chain Management Market

  • 18.1. France Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmaceutical Supply Chain Management Market

  • 19.1. Italy Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmaceutical Supply Chain Management Market

  • 20.1. Spain Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmaceutical Supply Chain Management Market

  • 21.1. Eastern Europe Pharmaceutical Supply Chain Management Market Overview
  • 21.2. Eastern Europe Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmaceutical Supply Chain Management Market

  • 22.1. Russia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmaceutical Supply Chain Management Market

  • 23.1. North America Pharmaceutical Supply Chain Management Market Overview
  • 23.2. North America Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmaceutical Supply Chain Management Market

  • 24.1. USA Pharmaceutical Supply Chain Management Market Overview
  • 24.2. USA Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmaceutical Supply Chain Management Market

  • 25.1. Canada Pharmaceutical Supply Chain Management Market Overview
  • 25.2. Canada Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmaceutical Supply Chain Management Market

  • 26.1. South America Pharmaceutical Supply Chain Management Market Overview
  • 26.2. South America Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmaceutical Supply Chain Management Market

  • 27.1. Brazil Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmaceutical Supply Chain Management Market

  • 28.1. Middle East Pharmaceutical Supply Chain Management Market Overview
  • 28.2. Middle East Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmaceutical Supply Chain Management Market

  • 29.1. Africa Pharmaceutical Supply Chain Management Market Overview
  • 29.2. Africa Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmaceutical Supply Chain Management Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Supply Chain Management Market Competitive Landscape
  • 30.2. Pharmaceutical Supply Chain Management Market Company Profiles
    • 30.2.1. McKesson Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. AmerisourceBergen Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Cardinal Health Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Oracle Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. SAP SE
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pharmaceutical Supply Chain Management Market Other Major And Innovative Companies

  • 31.1. DSV Panalpina
  • 31.2. UPS Healthcare
  • 31.3. Parexel International Corporation
  • 31.4. Spectrum Health Medical Group
  • 31.5. Vizient Inc
  • 31.6. Catalent Inc.
  • 31.7. Infor Inc.
  • 31.8. Epicor Software Corporation
  • 31.9. Alvogen Inc.
  • 31.10. Vetter Pharma International GmbH
  • 31.11. Almac Group
  • 31.12. Manhattan Associates Inc.
  • 31.13. Global Healthcare Exchange LLC
  • 31.14. CryoPDP
  • 31.15. Tecsys Inc.

32. Global Pharmaceutical Supply Chain Management Market Competitive Benchmarking

33. Global Pharmaceutical Supply Chain Management Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmaceutical Supply Chain Management Market

35. Pharmaceutical Supply Chain Management Market Future Outlook and Potential Analysis

  • 35.1 Pharmaceutical Supply Chain Management Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical Supply Chain Management Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical Supply Chain Management Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer